Dr. Kate Harkness, Ph.D., C.Psych.
Dr. Kate Harkness is a Professor and Head of the Psychology Department at Queen’s University. Her research focuses on the role of stress and early trauma in the etiology and ongoing pathology of major depression, and the neurobiological and cognitive-affective mechanisms that increase sensitivity to stress. Dr. Harkness is a Research Collaborator of the Canadian Biomarker Integration Network (CAN-BIND).
Dr. Claudio Soares, MD, Ph.D., MBA
Dr. Claudio Soares is a Professor in the Department of Psychiatry in the Queen’s University School of Medicine. He is also the Executive Lead and M-Health Research Lead for the Canadian Biomarker Integration Network in Depression (CAN-BIND). Dr. Soares’ research interests include effective treatments for mood disorders across the female life cycle, with particular emphasis on midlife women and the menopausal transition. His most recent research has focused on the use of mobile health technologies (M-Health) and the concept of digital phenotyping for a better understanding of sustained wellness, resilience and relapse in depression, as well as psilocybin-assisted treatment for alcohol use disorder.
Dr. Gustavo Vazquez, MD, PhD
Dr. Gustavo Vazquez is a professor in the Department of Psychiatry and Centre for Neurosciences at Queen’s University. He is also the Director CME and Clinical Lead Ketamine Clinic, at Providence Care Hospital in Kingston, Ontario and a Visiting Professor and Member of the International Consortium for Psychotic and Bipolar Disorders Research at McLean Hospital at Harvard Medical School in Boston, USA.
Dr. Christopher Bowie, Ph.D., C.Psych.
Dr. Christopher Bowie is a clinical psychologist and Professor with research interests in cognition and functional outcomes in schizophrenia and mood disorders. His work focuses on experimental studies of cognition and developing treatments to foster functioning and recovery. Two treatments from his lab, Action-Based Cognitive Remediation and Be Outspoken and Overcome Stigmatizing Thoughts, have been implemented at clinical and research sites around the world.
Dr. Elisa Brietzke, MD, MSc, PhD
Dr. Elisa M Brietzke is Professor of the Department of Psychiatry at Queen’s University School of Medicine and a member of the Centre for Neuroscience Studies (CNS) at Queen’s University as well. Her research is focused on neurobiology and innovative treatments for mood disorders, with a special interest in inflammation, metabolism, and nutrition in bipolar disorder and depression. She has co-authored more than 280 peer-reviewed publications and supervised 19 post-graduate students. She is interested in stimulating the engagement of young women in science, being part of several actions to create opportunities of professional development, mentorship, and visibility.
The Milev Lab 